Drawing for NEXUS

USPTO serial 98328473

NEXUS

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
LIU, PHILIP
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NEXUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard L. Byrne, Registration No. 28,498

Richard L. Byrne, Registration No. 28,498 THE WEBB LAW FIRMONE GATEWAY CENTER420 FORT DUQUESNE BOULEVARD, SUITE 1200PITTSBURGH, PA 15222

Goods and services

ClassDescriptionStatusFirst use
005Acai powder dietary supplements; Albumin dietary supplements; Alginate dietary supplements; Appetite stimulant preparations, namely, appetite suppressant pills; Bee glue in the nature of propolis for use as dietary supplements for human consumption; Brewer's yeast dietary supplements; Carbohydrate based dietary supplements; Casein dietary supplements; Cough sweets, namely, cough drops; Dietary fiber to aid digestion; Dietary fibre for treating constipation; Dietary food supplements; Dietary nutritional supplements; Dietary protein supplements; Dietary supplements; Dietary supplements for infants; Dietary supplements with a cosmetic effect; Digestants, namely, digestives for pharmaceutical purposes; Effervescent vitamin tablets; Electrolyte replacement beverages for medical purposes; Electrolyte replacement solutions for medical use; Enzyme dietary supplements; Extracts of medicinal herbs, other than essential oils, for medical purposes; Extracts of medicinal plants, other than essential oils, for medical purposes; Fibre dietary supplements; Gastrointestinal treatment preparations; Glucose dietary supplements; Herbal dietary supplements; Lactose nutritional supplement; Lecithin dietary supplements; Linseed dietary supplements; Linseed oil dietary supplements; Maltodextrins nutritional supplement; Medicated supplements for foodstuffs for human consumption; Milk calcium concentrate, namely, nutritional supplements; Milk sugar for medical purposes for use as nutritional supplements ; Mineral dietary supplements; Mineral dietary supplements for humans; Mineral preparations for medical purposes for use as nutritional additives to foodstuffs for humans; Mineral preparations for medical purposes for use as supplements to drinking water; Multivitamin preparations; Nutritional drinks being dietary food supplements, namely, fruit juices and energy drinks containing nutritional supplements; Nutritional protein supplement energy bars; Nutritional supplements; Nutritional supplements formed and packaged as bars; Plant extracts, for use as dietary supplements, other than essential oils, for pharmaceutical purposes; Pollen dietary supplement; Pollen dietary supplements; Pollen extracts, namely, processed bee pollen for medicinal or therapeutic purposes; Powdered whey protein being dietary supplements; Powdered whey protein being nutritional supplements; Probiotic bacterial dietary supplements; Propolis dietary supplements; Protein dietary supplements; Protein preparations for use as additives to foodstuffs, namely, whey protein dietary supplements for human consumption for medical purposes; Protein supplements for humans; Slimming pills; Dietetic sugar substitutes for diabetics for medical use; Vitamin C preparations; Dietary supplemental drinks in the nature of vitamin and mineral beverage; Vitamin preparations; Vitamin preparations for human consumption; Vitamin preparations in tablet form; Vitamin preparations in the nature of food supplements; Vitamin supplements; Vitamin supplements for foodstuffs for human consumption; Vitamin tablets; Vitamins; Wheat germ dietary supplements; Whey protein being dietary supplements; Whey protein being nutritional supplements; Whey protein concentrates being dietary supplements; Whey protein concentrates being nutritional supplements; Whey protein dietary supplements; Whey protein isolates being dietary supplements; Whey protein isolates being nutritional supplements; Yeast dietary supplementsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 7, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 7, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 7, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Oct 7, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 7, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 23, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 23, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 23, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 22, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Sep 9, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jul 5, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 4, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 4, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Jan 4, 2025CNSLSUSPENSION LETTER WRITTEN—
Jan 4, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 4, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Jan 4, 2025CNSLSUSPENSION LETTER WRITTEN—
Nov 6, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 6, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 6, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 6, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 6, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 6, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 24, 2024DOCKASSIGNED TO EXAMINER—
Feb 1, 2024MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 31, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 28, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance